Who should not take lurbinectedin, and why?
Lurbinectedin’s contraindications are driven by known risks from its use in cancer treatment, including severe bone-marrow suppression (low blood counts) and potential organ toxicity. Patients may be considered poor candidates when they have conditions that raise the likelihood of dangerous treatment-related complications.
What specific medical conditions can make lurbinectedin contraindicated?
The most common “do not use” scenarios for lurbinectedin in real-world practice usually relate to:
- Significant baseline blood-count problems (for example, very low neutrophils or platelets), because lurbinectedin can cause or worsen neutropenia and thrombocytopenia.
- Serious liver impairment, because lurbinectedin exposure can increase when hepatic function is reduced, raising the risk of toxicity.
If you have the product label for the exact lurbinectedin brand/formulation you’re asking about (and the indication, such as lung cancer vs. another tumor type), I can map the contraindications precisely to the label wording.
Are there contraindications related to pregnancy, breastfeeding, or fertility?
Lurbinectedin is typically treated as high-risk in pregnancy because of its cancer-drug mechanism and the general class risk of embryo-fetal harm. Breastfeeding is also generally avoided during treatment. These are often listed as contraindications or as conditions where use is not recommended depending on the regulatory label.
What counts as “potential contraindications” vs. “dose adjustments”?
Some situations may not be absolute contraindications on a label but still function like them clinically because treatment is paused or dose-reduced, for example:
- Moderate liver dysfunction
- Baseline cytopenias that can be corrected before the first dose
- Acute infections or other unstable conditions that increase the risk of complications
Label language varies by jurisdiction and indication, so the exact threshold values (and whether they are truly contraindications or require delays/dose reductions) depend on the prescribing information.
Quick way to get an exact contraindications list
If you share either:
1) the country/regulatory label you’re using (FDA, EMA, UK, etc.), or
2) a link/screenshot of the prescribing information section that lists contraindications,
I can extract the precise contraindication statements verbatim and explain what they mean for a patient.
Sources
I don’t have the lurbinectedin contraindications text from your provided materials or from an accessible label in this chat, so I can’t responsibly quote an exact list without risking inaccuracies.